FDA official offers overview of in-person, face-to-face ANDA meetings
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)ComplianceHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy